ArticleHealthcare (Basel, Switzerland)2022

Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study

Takumi Umemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.